Khiron Life Sciences’ CBD brand Kuida approved for Peruvian market

Khiron Life Sciences’ CBD brand Kuida approved for Peruvian market

Khiron has announced that it has received approval to commericalize and market four key products in its Kuida CBD cosmeceutical brand in Peru. Together with the authorization already rubber stamped for Mexico and Colombia, the Kuida brand will now be marketed to a combined population of nearly 200 million across Latin America.

“Khiron is entirely focused on the Latin American cannabis market and meeting the needs of its 620 million residents,” said Alvaro Torres, Co-founder and CEO for Khiron, “With today’s announcement to commercialize our Kuida brand in Peru, we expand our reach into an important new market. Peru is a region with a fast-growing cosmetic sector and an established legalized cannabis environment, which provides us with a strong foundation on which to build the Kuida brand.”

Launched in Colombia in September this year, Kuida is Khiron’s first consumer brand.

Leave a reply

Your email address will not be published. Required fields are marked *